SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1493)10/20/1998 10:04:00 AM
From: Walter Morton  Respond to of 2742
 
Is Genome Securities a new start up company financed by CIST?



To: Dr. John M. de Castro who wrote (1493)10/20/1998 10:07:00 AM
From: Walter Morton  Respond to of 2742
 
Just 11 more days before the announcement.....



To: Dr. John M. de Castro who wrote (1493)10/20/1998 12:35:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
If the 4 million share buyback was started at this moment Cistron would be trading at or above $1 a share by the close of trading today.

The book value of Cistron would also increase. Shareholders would be>>>"enhanced"

It is sooooo easy....Just match what the 2 officers have been paid since the IMNX settlement.

Why not? Hmmmmm.... No excuses left. See post #1460.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News